• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[经皮腔内血管成形术(PTA)联合朱安图尔科可扩张金属支架治疗佩吉特-施罗特综合征1例]

[A case of treatment of the Paget-Schroetter syndrome with PTA and Gianturco' expandable metallic stent].

作者信息

Inazawa K, Simanuki T, Minowa T, Iijima Y, Orita H, Washio M

机构信息

Second Department of Surgery, Yamagata University School of Medicine, Japan.

出版信息

Nihon Kyobu Geka Gakkai Zasshi. 1993 Aug;41(8):1410-4.

PMID:8360548
Abstract

We report a effective management of the Paget-Schroetter syndrome. A 23-year-old man was seen with a complaint of arm swelling and venous engorgement of the left arm. A first-rib resection was performed through a infraclavicular approach with removal of compressive elements including scalenus anterior and subclavius muscles. He became asymptomatic. But 2 months later, recurrent symptoms developed and venograms demonstrated the presence of restenosis of the subclavian vein with extensive collaterals. To relieve symptoms a percutaneous transluminal angioplasty (PTA) and a insertion and placement of the Gianturco's expandable metallic stents was carried out for the remaining stenosis of the subclavicular vein and a residual compression. Venograms, 7 months after operation, showed widely the patent subclavian vein. Trans-infraclavicular approach allowed exposure of the stenotic or obstructed segments of the subclavian vein. The PTA and stenting, especially after removal of compressive elements or during chronic phase, was a very useful and effective procedure for the treatment of the Paget-Schroetter syndrome.

摘要

我们报告了佩吉特-施罗特综合征的有效治疗方法。一名23岁男性因左臂肿胀和静脉充血前来就诊。通过锁骨下途径进行了第一肋切除术,切除了包括前斜角肌和锁骨下肌在内的压迫性组织。他症状消失。但2个月后,症状复发,静脉造影显示锁骨下静脉再狭窄并伴有广泛侧支循环。为缓解症状,对锁骨下静脉残余狭窄和残余压迫进行了经皮腔内血管成形术(PTA)以及置入和放置了吉安图尔科可扩张金属支架。术后7个月的静脉造影显示锁骨下静脉广泛通畅。经锁骨下途径可暴露锁骨下静脉的狭窄或阻塞段。PTA和支架置入术,尤其是在去除压迫性组织后或慢性期,是治疗佩吉特-施罗特综合征非常有用且有效的方法。

相似文献

1
[A case of treatment of the Paget-Schroetter syndrome with PTA and Gianturco' expandable metallic stent].[经皮腔内血管成形术(PTA)联合朱安图尔科可扩张金属支架治疗佩吉特-施罗特综合征1例]
Nihon Kyobu Geka Gakkai Zasshi. 1993 Aug;41(8):1410-4.
2
Primary subclavian-axillary vein thrombosis: the relative roles of thrombolysis, percutaneous angioplasty, stents, and surgery.原发性锁骨下-腋静脉血栓形成:溶栓、经皮血管成形术、支架置入及手术的相对作用
Semin Vasc Surg. 1998 Jun;11(2):91-5.
3
Surgery remains the most effective treatment for Paget-Schroetter syndrome: 50 years' experience.手术仍然是佩吉特-施罗特综合征最有效的治疗方法:50年的经验。
Ann Thorac Surg. 2008 Jul;86(1):254-60; discussion 260. doi: 10.1016/j.athoracsur.2008.03.021.
4
Paget-Schroetter syndrome treated with cutting-balloon angioplasty.切割球囊血管成形术治疗佩吉特-施罗氏综合征。
Cardiovasc Intervent Radiol. 2012 Jun;35(3):686-9. doi: 10.1007/s00270-011-0245-4. Epub 2011 Aug 16.
5
Effort thrombosis of the axillosubclavian vein: a disabling vascular disorder.腋-锁骨下静脉用力性血栓形成:一种致残性血管疾病。
Compr Ther. 1991 May;17(5):18-24.
6
[The use of intravascular nitinol stents in the treatment of subclavian vein compression for thoracic outlet syndrome].[血管内镍钛诺支架在治疗胸廓出口综合征锁骨下静脉受压中的应用]
Polim Med. 2007;37(2):51-5.
7
[Paget-Schroetter disease: clinical and therapeutic considerations].[佩吉特-施罗特病:临床与治疗考量]
Chir Ital. 2002 Sep-Oct;54(5):729-36.
8
Long-term results in patients treated with thrombolysis, thoracic inlet decompression, and subclavian vein stenting for Paget-Schroetter syndrome.采用溶栓、胸廓入口减压及锁骨下静脉支架置入术治疗Paget-Schroetter综合征患者的长期结果。
J Vasc Surg. 2001 Feb;33(2 Suppl):S100-5. doi: 10.1067/mva.2001.111664.
9
Paget-Schroetter syndrome treated with thrombolytics and immediate surgery.采用溶栓药物及即刻手术治疗的上肢深静脉血栓形成综合征
J Vasc Surg. 2007 Feb;45(2):328-34. doi: 10.1016/j.jvs.2006.09.052.
10
Paget-Schroetter syndrome therapy: failure of intravenous stents.
Ann Thorac Surg. 2003 Jun;75(6):1693-6; discussion 1696. doi: 10.1016/s0003-4975(03)00116-4.